Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction

Tuncel A., Nalcacioglu V., Ener K., Aslan Y., Aydin O., Atan A.

WORLD JOURNAL OF UROLOGY, vol.28, no.1, pp.17-22, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 28 Issue: 1
  • Publication Date: 2010
  • Doi Number: 10.1007/s00345-009-0484-z
  • Journal Name: WORLD JOURNAL OF UROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.17-22
  • Keywords: Benign prostate hyperplasia, Lower urinary tract symptoms, Erectile dysfunction, Sildenafil citrate, Tamsulosin, BENIGN PROSTATIC HYPERPLASIA, SEXUAL FUNCTION, MEN, SECONDARY, TADALAFIL, EFFICACY
  • Gazi University Affiliated: No

Abstract

To evaluate the efficacy of sildenafil citrate only, 25 mg. Four times/week, tamsulosin only, 0.4 mg once daily, and the combination of both on lower urinary tract symptoms (LUTS) suggestive of benign prostate hyperplasia (BPH) and erectile dysfunction.